Application of O-(piperazinyl) ethyl derivative of cleistanone to preparation of medicine for resisting erythrocyte hypoplastic anemia
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 冬青南京生物科技有限公司
- Publication Date
- 2015-01-21
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the fields of organic synthesis and medicinal chemistry, in particular to O-(piperazinyl)ethyl derivatives of cleusenone, a preparation method and uses thereof. Background technique
[0002] There are different classifications of anemia based on different clinical features. Such as: acute and chronic anemia according to the progress of anemia; proliferative anemia (such as hemolytic anemia, iron deficiency anemia, megaloblastic anemia, etc.) and hypoplastic anemia (such as aplastic anemia) ).
[0003] Clinically, it is often classified from the pathogenesis and etiology of anemia:
[0004] 1. Hemorrhagic anemia
[0005] According to the rate of blood loss, it can be divided into acute and chronic, and chronic hemorrhagic anemia is often combined with iron deficiency anemia. It can be divided into coagulation diseases (such as idiopathic thrombocytopenic purpura, hemophilia and severe liver disease, etc.) and non-coagulation...